Skip to main content
Clinical Trials/CTRI/2018/12/016739
CTRI/2018/12/016739
Completed
Phase 4

Comparison of efficacy of intrathecal nalbuphine vs fentanyl as adjuvant to subarachnoid block in caesarean section.

SHANMUGAVALLI E0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: O94-O9A- Other obstetric conditions, not elsewhere classified
Sponsor
SHANMUGAVALLI E
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
SHANMUGAVALLI E

Eligibility Criteria

Inclusion Criteria

  • ASA Physical statusII
  • Weight between 50 to 80 kilogram
  • Height between 150 to 160 cm
  • Cesarean section

Exclusion Criteria

  • ASA Physical status III,IV and V.patients receiving long term analgesic therapy,hypnotics or long term CNS depressants.Peripheral neuropathy.cogulopathy,infction at the site of injection.cardiac,hepatic or renal diseases.

Outcomes

Primary Outcomes

Not specified

Similar Trials